About Cycle Pharmaceuticals
We are passionate about developing medicines for patients with rare diseases. We focus on rare metabolic, immunological and neurological genetic conditions, in particular, hereditary tyrosinemia type 1 (HT-1), phenylketonuria (PKU) and hereditary angioedema (HAE). We utilise proprietary pharmaceutical technologies to deliver the required medicine with the minimum impact on daily routines. We also provide individualised patient-support services alongside it. Medicines for rare diseases are at the heart of what we do, because every single patient matters.
We will be celebrating rare disease day by raising awareness about rare diseases online, in particular the ones we focus on, and about the importance of equity.